Using a Discrete-Choice Experiment in a Decision Aid to Nudge Patients Towards Value-Concordant Treatment Choices in Rheumatoid Arthritis: A Proof-of-Concept Study

References

• Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheum. 2016;68(1):1–26. doi:10.1002/art.39480
   PubMed Web of Science ®Google Scholar
• Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe DJ, Bombardier C. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: a network meta-analysis. Cochrane Database Syst Rev. 2016;8:CD010227.
   Google Scholar
• Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe D, Bombardier C. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis. BMJ. 2016;353:i1777. doi:10.1136/bmj.i1777
   PubMed Web of Science ®Google Scholar
• Fraenkel L, Miller AS, Clayton K, et al. When patients write the guidelines: patient panel recommendations for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2016;68(1):26–35. doi:10.1002/acr.22758
   Web of Science ®Google Scholar
• Hazlewood GS, Bombardier C, Tomlinson G, Marshall D. A Bayesian model that jointly considers comparative effectiveness research and patients’ preferences may help inform GRADE recommendations: an application to rheumatoid arthritis treatment recommendations. J Clin Epidemiol. 2018;93:56–65. doi:10.1016/j.jclinepi.2017.10.003
   Web of Science ®Google Scholar
• Hazlewood GS, Bombardier C, Tomlinson G, et al. Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment. Rheumatology (Oxford). 2016;55(11):1959–1968. doi:10.1093/rheumatology/kew280
   Web of Science ®Google Scholar
• Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4:CD001431.
   PubMed Web of Science ®Google Scholar
• O’Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995;15(1):25–30. doi:10.1177/0272989X9501500105
   PubMed Web of Science ®Google Scholar
• Legare F, Kearing S, Clay K, et al. Are you SURE?: assessing patient decisional conflict with a 4-item screening test. Can Fam Physician. 2010;56(8):e308–314.
   PubMed Web of Science ®Google Scholar
• Pablos JL, Jover JA, Roman-Ivorra JA, et al. Patient Decision Aid (PDA) for patients with rheumatoid arthritis reduces decisional conflict and improves readiness for treatment decision making. Patient. 2019; 13(1):57–69.
   Google Scholar
• Fraenkel L, Matzko CK, Webb DE, et al. Use of decision support for improved knowledge, values clarification, and informed choice in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2015;67(11):1496–1502. doi:10.1002/acr.22659
   Web of Science ®Google Scholar
• Sepucha KR, Borkhoff CM, Lally J, et al. Establishing the effectiveness of patient decision aids: key constructs and measurement instruments. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S12. doi:10.1186/1472-6947-13-S2-S12
   Google Scholar
• Fagerlin A, Pignone M, Abhyankar P, et al. Clarifying values: an updated review. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S8. doi:10.1186/1472-6947-13-S2-S8
   PubMed Web of Science ®Google Scholar
• Witteman HO, Scherer LD, Gavaruzzi T, et al. Design features of explicit values clarification methods: a systematic review. Med Decis Making. 2016;36(4):453–471. doi:10.1177/0272989X15626397
   PubMed Web of Science ®Google Scholar
• Witteman HO, Gavaruzzi T, Scherer LD, et al. Effects of design features of explicit values clarification methods: a systematic review. Med Decis Making. 2016;36(6):760–776. doi:10.1177/0272989X16634085
   PubMed Web of Science ®Google Scholar
• Blumenthal-Barby JS, Cantor SB, Russell HV, Naik AD, Volk RJ. Decision aids: when ‘nudging’ patients to make a particular choice is more ethical than balanced, nondirective content. Health Aff (Millwood). 2013;32(2):303–310. doi:10.1377/hlthaff.2012.0761
   Web of Science ®Google Scholar
• Bansback N, Li LC, Lynd L, Bryan S. Development and preliminary user testing of the DCIDA (dynamic computer interactive decision application) for ‘nudging’ patients towards high quality decisions. BMC Med Inform Decis Mak. 2014;14(1):62. doi:10.1186/1472-6947-14-62
   Google Scholar
• Elwyn G, O’Connor A, Stacey D, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333(7565):417. doi:10.1136/bmj.38926.629329.AE
   PubMed Web of Science ®Google Scholar
• Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9(5):789–793.
   PubMed Web of Science ®Google Scholar
• Bangor A, Kortum PT, Miller JT. An empirical evaluation of the system usability scale. Int J Hum Comput Interact. 2008;24(6):574–594. doi:10.1080/10447310802205776
   Web of Science ®Google Scholar
• Barber CEH, Sandhu N, Rankin JA, et al. Rheum4U: development and testing of a web-based tool for improving the quality of care for patients with rheumatoid arthritis. Clin Exp Rheumatol. 2018 37(3):385–92.
   Web of Science ®Google Scholar
• Munro S, Stacey D, Lewis KB, Bansback N. Choosing treatment and screening options congruent with values: do decision aids help? Sub-analysis of a systematic review. Patient Educ Couns. 2016;99(4):491–500. doi:10.1016/j.pec.2015.10.026
   Web of Science ®Google Scholar
• Matheis-Kraft C, Roberto KA. Influence of a values discussion on congruence between elderly women and their families on critical health care decisions. J Women Aging. 1997;9(4):5–22. doi:10.1300/J074v09n04_02
   PubMed Web of Science ®Google Scholar
• Montgomery AA, Fahey T, Peters TJ. A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients. Br J Gen Pract. 2003;53(491):446–453.
   Web of Science ®Google Scholar
• O’Connor AM, Wells GA, Tugwell P, Laupacis A, Elmslie T, Drake E. The effects of an ‘explicit’ values clarification exercise in a woman’s decision aid regarding postmenopausal hormone therapy. Health Expect. 1999;2(1):21–32. doi:10.1046/j.1369-6513.1999.00027.x
   Google Scholar
• Sheridan SL, Griffith JM, Behrend L, Gizlice Z, Cai J, Pignone MP. Effect of adding a values clarification exercise to a decision aid on heart disease prevention: a randomized trial. Med Decis Making. 2010;30(4):E28–39. doi:10.1177/0272989X10369008
   Web of Science ®Google Scholar
• Weernink MGM, van Til JA, Witteman HO, Fraenkel L, IJzerman MJ. Individual value clarification methods based on conjoint analysis: a systematic review of common practice in task design, statistical analysis, and presentation of results. Med Decis Making. 2018;38(6):746–755. doi:10.1177/0272989X18765185
   Web of Science ®Google Scholar
• Bansback N, Bell M, Spooner L, Pompeo A, Han PKJ, Harrison M. Communicating uncertainty in benefits and harms: a review of patient decision support interventions. Patient. 2017;10(3):311–319. doi:10.1007/s40271-016-0210-z
   Google Scholar
• Ellsberg D. Risk, ambiguity, and the Savage axioms. Q J Econ. 1961;75(4):643–669. doi:10.2307/1884324
   Web of Science ®Google Scholar
• Durand C, Eldoma M, Marshall DA, Hazlewood GS. Patient preferences for disease modifying anti-rheumatic drug treatment in rheumatoid arthritis: a systematic review. J Rheumatol. 2019;47(2):176–87.
   Web of Science ®Google Scholar
• Harris JA, Bykerk VP, Hitchon CA, et al. Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort. J Rheumatol. 2013;40(11):1823–1830. doi:10.3899/jrheum.121316
   Web of Science ®Google Scholar
• de Jong PH, Hazes JM, Buisman LR, et al. Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial. Rheumatology (Oxford). 2016;55(12):2138–2147. doi:10.1093/rheumatology/kew321
   Web of Science ®Google Scholar